Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Transforming growth factor-beta in systemic sclerosis (scleroderma)
John Varga
*
, Michael L. Whitfield
*
Corresponding author for this work
Dermatology
Research output
:
Contribution to journal
›
Article
›
peer-review
82
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Transforming growth factor-beta in systemic sclerosis (scleroderma)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antifibrotic
25%
Biological Activity
25%
Clinical Manifestations
25%
Clinical Patients
25%
Connective Tissue Disease
25%
Fibroblasts
25%
Fibrosis
25%
Gene Expression
25%
Highly Heterogeneous
25%
Internal Organs
25%
Intracellular Signaling
25%
Molecular Signature
25%
Multigroup
25%
Scleroderma
100%
Systemic Sclerosis
100%
Target Organ
25%
Targeted Therapy
25%
Transcriptional Profiling
25%
Transforming Growth Factor-β
100%
Immunology and Microbiology
Beta Rhythm
25%
Biological Activity
25%
Connective Tissue
25%
Fibroblast
25%
Gene Expression
25%
Gene Expression Assay
25%
Intracellular Signaling
25%
Scleroderma
100%
Systemic Scleroderma
100%
Target Organ
25%
Transforming Growth Factor Beta
100%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Activity
25%
Connective Tissue Disease
25%
Fibrosis
25%
Scleroderma
100%
Systemic Sclerosis
100%
Transforming Growth Factor Beta
100%
Biochemistry, Genetics and Molecular Biology
Beta Wave
33%
Biological Activity
33%
Fibroblast
33%
Gene Expression
33%
Gene Expression Profiling
33%
Intracellular Signaling
33%
Target Organ
33%
Transforming Growth Factor Beta
100%
Neuroscience
Connective Tissue
33%
Fibroblast
33%
Gene Expression
33%
Intracellular Signaling
33%
Transforming Growth Factor Beta
100%